Needham analyst Kyle Peterson raised the firm’s price target on Cardlytics (CDLX) to $15 from $12 and keeps a Buy rating on the shares. The company’s Q4 results were in-line with its pre-announcement in January as advertiser spend improved throughout the quarter, the analyst tells investors in a research note. Cardlytics’ Q1 outlook was also solid, and the company announced that it has signed a three-year contract to provide card-linked offers for American Express (AXP) – the second largest credit card issuer in the U.S., the firm added, calling this a landmark win that should provide increased access to consumer transaction data.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CDLX:
- Cardlytics Inc to Share Insightful Presentation for Investors
- Cardlytics Announces Fourth Quarter and Full Year 2023 Financial Results
- Cardlytics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
- Cardlytics, Inc. (CDLX) Q4 Earnings Cheat Sheet